메뉴 건너뛰기
Nephron - Clinical Practice
Volumn 119, Issue 1, 2011, Pages
Survival analysis I: The Kaplan-Meier method
Author keywords

Epidemiology; Kaplan Meier method; Nephrology; Survival analysis
Indexed keywords

ARTICLE; CONTROLLED STUDY; HUMAN; KAPLAN MEIER METHOD; KIDNEY FAILURE; LOG RANK TEST; MAJOR CLINICAL STUDY; MORTALITY; MULTIPLE MYELOMA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; SURVIVAL; SURVIVAL RATE; SURVIVAL TIME;
EID: 79958767510     PISSN: None     EISSN: 16602110     Source Type: Journal    
DOI: 10.1159/000324758     Document Type: Article
Times cited : (103)
References (11)
  • 1
    • 40449107836 scopus 로고    scopus 로고
    • Association of activated vitamin D treatment and mortality in chronic kidney disease
    • DOI 10.1001/archinternmed.2007.110
    • Kovesdy CP, Ahmadzadeh S, Anderson JE, Kalantar-Zadeh K: Association of activated vitamin D treatment and mortality in chronic kidney disease. Arch Intern Med 2008; 168: 397-403. (Pubitemid 351350586)
    • (2008) Archives of Internal Medicine , vol.168 , Issue.4 , pp. 397-403
    • Kovesdy, C.P.1    Ahmadzadeh, S.2    Anderson, J.E.3    Kalantar-Zadeh, K.4
  • 2
    • 67649616482 scopus 로고    scopus 로고
    • Risk of fractures after renal transplantation in the United States
    • Nikkel LE, Hollenbeak CS, Fox EJ, et al: Risk of fractures after renal transplantation in the United States. Transplantation 2009; 87: 1846-1851.
    • (2009) Transplantation , vol.87 , pp. 1846-1851
    • Nikkel, L.E.1    Hollenbeak, C.S.2    Fox, E.J.3
  • 4
    • 77950270513 scopus 로고    scopus 로고
    • Incidence and outcome of patients starting renal replacement therapy for end-stage renal disease due to multiple myeloma or light-chain deposit disease: An ERA-EDTA Registry study
    • Tsakiris DJ, Stel VS, Finne P, et al: Incidence and outcome of patients starting renal replacement therapy for end-stage renal disease due to multiple myeloma or light-chain deposit disease: An ERA-EDTA Registry study. Nephrol Dial Transplant 2010; 25: 1200-1206.
    • (2010) Nephrol Dial Transplant , vol.25 , pp. 1200-1206
    • Tsakiris, D.J.1    Stel, V.S.2    Finne, P.3
  • 5
    • 0032528710 scopus 로고    scopus 로고
    • Time to event (survival) data
    • Altman DG, Bland JM: Time to event (survival) data. BMJ 1998; 317: 468-469.
    • (1998) BMJ , vol.317 , pp. 468-469
    • Altman, D.G.1    Bland, J.M.2
  • 6
    • 33646842210 scopus 로고    scopus 로고
    • Survival probabilities (the Kaplan-Meier method
    • Bland JM, Altman DG: Survival probabilities (the Kaplan-Meier method). BMJ 1998; 317: 1572.
    • (1998) BMJ , vol.317 , pp. 1572
    • Bland, J.M.1    Altman, D.G.2
  • 7
    • 78650632320 scopus 로고    scopus 로고
    • The analysis of competing events like cause-specific mortality - beware of the Kaplan- Meier method
    • Verduijn M, Grootendorst DC, Dekker FW, et al: The analysis of competing events like cause-specific mortality - beware of the Kaplan- Meier method. Nephrol Dial Transplant 2010; 26: 56-61.
    • (2010) Nephrol Dial Transplant , vol.26 , pp. 56-61
    • Verduijn, M.1    Grootendorst, D.C.2    Dekker, F.W.3
  • 10
    • 2342659010 scopus 로고    scopus 로고
    • The logrank test
    • Bland JM, Altman DG: The logrank test. BMJ 2004; 328: 1073.
    • (2004) BMJ , vol.328 , pp. 1073
    • Bland, J.M.1    Altman, D.G.2
  • 11
    • 0037062129 scopus 로고    scopus 로고
    • Survival plots of time-to-event outcomes in clinical trials: Good practice and pitfalls
    • DOI 10.1016/S0140-6736(02)08594-X
    • Pocock SJ, Clayton TC, Altman DG: Survival plots of time-to-event outcomes in clinical trials: Good practice and pitfalls. Lancet 2002; 359: 1686-1689. (Pubitemid 34518535)
    • (2002) Lancet , vol.359 , Issue.9318 , pp. 1686-1689
    • Pocock, S.J.1    Clayton, T.C.2    Altman, D.G.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.